BioMed Stock Hits New 52-Week High (BMR)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- BioMed Realty (NYSE: BMR) hit a new 52-week high Tuesday as it is currently trading at $22.91, above its previous 52-week high of $22.88 with 823,852 shares traded as of 3:16 p.m. ET. Average volume has been 1.9 million shares over the past 30 days.

BioMed has a market cap of $4.19 billion and is part of the financial sector and real estate industry. Shares are up 18.3% year to date as of the close of trading on Monday.

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT) that focuses on providing real estate to the life science industry in the United States. The company has a P/E ratio of 749.7, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates BioMed as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in net income and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and poor profit margins. You can view the full BioMed Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.
null

If you liked this article you might like

BioMed Realty (BMR) Marked As A Barbarian At The Gate

3 Hold-Rated Dividend Stocks: SEAS, BMR, TGH

3 Real Estate Stocks Moving The Industry Upward

BioMed Realty Just One of Blackstone's Latest Multi-Billion-Dollar Deals

Jim Cramer -- REIT Sector Hammered but Still Buying Opportunities